Related Experiment Video
Updated: Aug 3, 2026

PLGA Nanoparticles Formed by Single- or Double-emulsion with Vitamin E-TPGS
Published on: December 27, 2013
Failure of vitamin E in clinical trials: is gamma-tocopherol the answer?
Sridevi Devaraj1, Ishwarlal Jialal
1Laboratory for Atherosclerosis and Metabolic Research, Department of Pathology and Laboratory Medicine, University of California-Davis Medical Center, Sacramento, USA.
Abstract:
Oxidative stress and inflammation play a crucial role in atherosclerosis. However, prospective clinical trials of dietary antioxidants with anti-inflammatory properties, such as alpha-tocopherol (AT), have not yielded positive results. AT supplementation decreases gamma-tocopherol (GT) levels. GT is an antioxidant with potent anti-inflammatory activity, and plasma GT levels are inversely associated with cardiovascular diseases. Thus, studies using pure GT, alone or in conjunction with AT, will elucidate its utility in cardiovascular disease prevention.
Insights
Oxidative stress and inflammation are key in atherosclerosis. Studies on alpha-tocopherol (AT) failed, possibly due to decreased gamma-tocopherol (GT), an antioxidant with anti-inflammatory effects beneficial for cardiovascular health.
Area of Science:
- Cardiovascular Science
- Nutritional Biochemistry
- Oxidative Stress Research
Background:
- Atherosclerosis pathogenesis involves oxidative stress and inflammation.
- Clinical trials of alpha-tocopherol (AT) for cardiovascular disease prevention have been unsuccessful.
- AT supplementation is linked to reduced levels of gamma-tocopherol (GT).
Purpose of the Study:
- To investigate the role of gamma-tocopherol (GT) in cardiovascular disease (CVD) prevention.
- To evaluate the therapeutic potential of GT, alone or combined with AT.
- To understand the relationship between GT, AT, and atherosclerosis.
Main Methods:
- Review of existing clinical trial data on AT and tocopherol levels.
- Analysis of the antioxidant and anti-inflammatory properties of GT.
- Correlation analysis between plasma GT levels and cardiovascular disease incidence.
Main Results:
- Plasma GT levels are inversely associated with cardiovascular disease risk.
- GT exhibits potent antioxidant and anti-inflammatory activities.
- AT supplementation negatively impacts GT levels.
Conclusions:
- Gamma-tocopherol (GT) shows promise for cardiovascular disease prevention.
- Further research using pure GT, alone or with AT, is warranted.
- Understanding tocopherol interactions is crucial for effective CVD prevention strategies.
More Related Videos
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
05:03Quantitative Analysis of Dietary Vitamin A Metabolites in Murine Ocular and Non-Ocular Tissues Using High-Performance Liquid Chromatography
Published on: December 27, 2024
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Vitamins